Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
0,7861 USD | +3,57% | +4,81% | -58,41% |
Attività
Numero di dipendenti: 344
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Consumables
30,9
%
| 7 | 24,2 % | 11 | 30,9 % | +65,76% |
Instruments
27,7
%
| 9 | 30,8 % | 10 | 27,7 % | +16,72% |
Services and Other
26,0
%
| 7 | 26,5 % | 9 | 26,0 % | +27,27% |
Software
15,4
%
| 5 | 18,4 % | 6 | 15,4 % | +8,66% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
44,0
%
| 12 | 42,0 % | 16 | 44,0 % | +36,09% |
EMEA
35,9
%
| 9 | 32,2 % | 13 | 35,9 % | +44,68% |
China
10,0
%
| 1 | 2,5 % | 4 | 10,0 % | +418,01% |
Americas
5,9
%
| 2 | 7,9 % | 2 | 5,9 % | -2,57% |
Asia Pacific
4,2
%
| 4 | 15,4 % | 2 | 4,2 % | -64,48% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Robert Holmlin
CEO | Chief Executive Officer | 56 | 12/01/11 |
Gülsen Kama
DFI | Director of Finance/CFO | 51 | 11/09/23 |
Shroff Hema
CTO | Chief Tech/Sci/R&D Officer | - | - |
Hastie Alex
CTO | Chief Tech/Sci/R&D Officer | - | - |
Alka Chaubey
CTO | Chief Tech/Sci/R&D Officer | 51 | 31/08/20 |
Mark Oldakowski
COO | Chief Operating Officer | 50 | 01/10/14 |
Marin Stanislas
SAM | Sales & Marketing | - | - |
Jonathan Dixon
LAW | General Counsel | - | 01/01/23 |
Helene Klein
HRO | Human Resources Officer | - | 14/02/22 |
Mark Adamchak
AUD | Comptroller/Controller/Auditor | - | - |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Director/Board Member | 64 | 01/07/18 | |
David Barker
CHM | Chairman | 82 | 11/05/10 |
Albert Luderer
BRD | Director/Board Member | 75 | 01/10/11 |
Robert Holmlin
CEO | Chief Executive Officer | 56 | 12/01/11 |
Kristiina Vuori
BRD | Director/Board Member | 56 | 06/06/19 |
Hannah Mamuszka
BRD | Director/Board Member | 47 | 04/05/20 |
Director/Board Member | - | 17/02/22 | |
Yvonne Linney
BRD | Director/Board Member | 62 | 04/05/20 |
Vincent J. Wong
BRD | Director/Board Member | - | 22/12/21 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 52 288 682 | 52 028 268 ( 99,50 %) | 0 | 99,50 % |
Coordinate società
Bionano Genomics, Inc.
9540 Towne Centre Drive Suite 100
92121, San Diego
+858 888 7600
http://www.bionanogenomics.comSettore
Vendite per attività
Vendite per regione
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
-58,41% | 48,13 Mln | |
+8,07% | 219 Mrd | |
+6,59% | 183 Mrd | |
+11,26% | 133 Mrd | |
+26,57% | 108 Mrd | |
+0,65% | 63,06 Mrd | |
+13,35% | 52,02 Mrd | |
-0,62% | 48,2 Mrd | |
-0,93% | 40,37 Mrd | |
+11,54% | 39,35 Mrd |
- Borsa valori
- Azioni
- Azione BNGO
- Società Bionano Genomics, Inc.